Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/15/16 | Current report filing |
|
8 | ||
| 03/04/16 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 03/03/16 | Current report filing |
|
3 | ||
| 03/01/16 | Initial statement of beneficial ownership of securities |
|
4 | ||
| 02/25/16 | Current report filing |
|
3 | ||
| 02/22/16 | Current report filing |
|
6 | ||
| 02/16/16 | Annual statement of changes in beneficial ownership of securities |
|
1 | ||
| 12/10/15 | Current report filing |
|
38 | ||
| 11/13/15 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
76 | |
| 11/12/15 | Current report filing |
|
10 |